Complete Filing Data
Regencell Bioscience Holdings Ltd reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $4.86 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Regencell Bioscience Holdings Ltd did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$3.6M | -$4.3M | -$5.9M | -$7.4M | -$1.3M | -$812.4K | -$391.0K |
| Selling And Marketing Expense | $8.0K | $125.4K | $262.7K | $25.3K | $1.6K | $114.2K | $3.6K |
| Research And Development Expense | $948.3K | $1.1M | $1.6M | $2.5M | $438.3K | $386.2K | $228.2K |
| Operating Income Loss | -$3.8M | -$4.7M | -$6.3M | -$7.6M | -$1.4M | -$812.4K | -$391.0K |
| Operating Expenses | $3.8M | $4.7M | $6.3M | $7.6M | $1.4M | $812.4K | $391.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$3.6M | -$4.4M | -$6.1M | -$7.6M | -$1.3M | -$812.4K | -$391.0K |
| General And Administrative Expense | $2.8M | $3.5M | $4.4M | $5.1M | $941.5K | $311.9K | $159.1K |
| Comprehensive Income Net Of Tax | -$3.6M | -$4.3M | -$6.1M | -$7.6M | -$1.3M | -$812.4K | -$391.0K |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $61.4K | $191.2K | $148.6K | -$1.3M | -$812.4K | ||
| Net Income Loss Attributable To Noncontrolling Interest | -$61.4K | -$191.2K | -$148.6K | ||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$19.0K | $40.9K | -$86.7K | ||||
| Net Income Loss Available To Common Stockholders Basic | -$6.0M | -$7.4M | -$1.3M | $812.4K | |||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$3.6M | -$4.3M | -$6.0M | -$7.4M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $4.9M | $8.2M | $12.0M | $17.1M | -$4.0M | -$2.7M | -$1.8M | -$1.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.4M | $3.0M | $1.6M | $6.4M | $59.4K | $387.0K | $243.3K | |
| Retained Earnings Accumulated Deficit | -$25.2M | -$21.6M | -$17.3M | -$11.4M | -$4.0M | -$2.7M | ||
| Property Plant And Equipment Net | $215.4K | $141.7K | $440.8K | $712.6K | $81.9K | $108.3K | ||
| Liabilities Current | $663.7K | $193.6K | $606.9K | $577.8K | $4.3M | $3.2M | ||
| Liabilities And Stockholders Equity | $5.8M | $8.4M | $12.6M | $18.0M | $340.1K | $514.0K | ||
| Liabilities | $895.3K | $219.5K | $632.3K | $938.0K | $4.3M | $3.2M | ||
| Deposits Assets Noncurrent | $93.0K | $97.7K | $108.5K | $114.3K | $19.1K | $18.7K | ||
| Common Stock Value | $4.9K | $130.00 | $130.00 | $130.00 | $100.00 | $100.00 | ||
| Assets Noncurrent | $852.8K | $324.2K | $1.0M | $1.6M | $273.3K | $127.0K | ||
| Assets Current | $4.9M | $8.1M | $11.6M | $16.4M | $66.8K | $387.0K | ||
| Assets | $5.8M | $8.4M | $12.6M | $18.0M | $340.1K | $514.0K | ||
| Accrued Liabilities Current | $348.4K | $125.3K | $158.1K | $151.1K | $573.0K | $95.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$542.1K | $1.4M | -$4.9M | $6.4M | -$327.6K | |||
| Finance Lease Right Of Use Asset Amortization | $315.1K | $439.8K | $476.6K | $454.3K | ||||
| Short Term Investments | $2.5M | $5.0M | $10.0M | $10.0M | ||||
| Operating Lease Right Of Use Asset | $544.4K | $84.8K | $451.1K | $747.4K | ||||
| Operating Lease Liability Noncurrent | $231.6K | $25.9K | $25.4K | $360.3K | ||||
| Operating Lease Liability Current | $312.8K | $59.8K | $438.3K | $411.0K | ||||
| Cash And Cash Equivalents At Carrying Value | $6.4M | $59.4K | $387.0K | $243.3K | $153.3K | |||
| Cash | $6.4M | $59.4K | $387.0K | $243.3K | $153.3K | |||
| Additional Paid In Capital Common Stock | $30.1M | $29.9M | $29.4M | $28.5M | ||||
| Rightofuse Assets Obtained In Exchange Of Lease Liabilities | $71.1K | $189.8K | $1.4M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$64.8K | -$45.8K | -$86.7K | |||||
| Minority Interest | -$40.9K | $15.4K | ||||||
| Right Of Use Asset Obtained In Exchange For Finance Lease Liability | $778.6K | $71.1K | $189.8K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$3.1M | -$4.0M | -$5.0M | -$5.3M | -$767.3K | -$726.6K | -$391.0K |
| Net Cash Provided By Used In Financing Activities | $102.3K | $134.9K | $22.4M | $439.7K | $988.1K | $481.0K | |
| Payments To Acquire Property Plant And Equipment | $152.7K | $5.4K | $27.4K | $780.9K | $117.8K | ||
| Net Cash Provided By Used In Investing Activities | $2.7M | $5.2M | $59.0K | -$10.8M | -$117.8K | ||
| Share Based Compensation | $244.8K | $449.3K | $922.6K | $2.8M | |||
| Payments To Acquire Short Term Investments | $32.5M | $5.0M | $10.0M | $10.0M | |||
| Increase Decrease In Prepaid Expenses Other | -$147.0K | $96.2K | $29.0K | $9.4K | $7.4K | ||
| Increase Decrease In Operating Liabilities | -$350.0K | -$465.1K | -$487.7K | -$430.4K | |||
| Increase Decrease In Due To Other Related Parties | -$5.9K | -$2.1K | -$5.1K | -$67.2K | $82.8K | ||
| Increase Decrease In Deposit Other Assets | -$4.7K | -$10.8K | -$5.8K | $95.2K | $388.00 | ||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $223.0K | -$32.8K | $7.0K | -$421.9K | $478.0K | ||
| Proceeds From Minority Shareholders | $102.3K | $134.9K | $164.0K | ||||
| Proceeds From Sale Of Short Term Investments | $35.3M | $10.2M | $10.1M | ||||
| Proceeds From Repayments Of Short Term Debt | -$432.0K | $612.1K | $988.1K | ||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$114.8K | $53.2K | -$83.1K | ||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $244.8K | $449.3K | $922.6K | $2.8M | |||
| Increase Decrease In Inventory For Long Term Contracts Or Programs | $95.2K | $388.00 | $18.7K | ||||
| Proceeds From Sale Of Property Plant And Equipment | $970.00 | ||||||
| Proceeds From Repayments Of Related Party Debt | -$67.2K | $82.8K | |||||
| Proceeds From Issuance Of Other Long Term Debt | $612.1K | $988.1K | $481.0K | ||||
| Proceeds From Issuance Initial Public Offering | $22.7M | ||||||
| Payments Of Stock Issuance Costs | $172.3K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 494.5M | 494.5M | 494.5M | 12.8M | 10.0M | 10.0M | 0.04 |
| Weighted Average Number Of Diluted Shares Outstanding | 494.5M | 494.5M | 494.5M | 12.8M | 10.0M | 10.0M | |
| Earnings Per Share Diluted | $-0.72 | $-0.87 | $-1.19 | $-0.58 | $-0.13 | $-0.08 | |
| Earnings Per Share Basic | $-0.72 | $-0.87 | $-1.19 | $-0.58 | $0.13 | $0.08 | |
| Common Stock Shares Outstanding | 494.5M | 494.5M | 13.0M | 13.0M | 10.0M | 10.0M | |
| Common Stock Shares Issued | 494.5M | 494.5M | 13.0M | 13.0M | 10.0M | 10.0M | |
| Common Stock Shares Authorized | 100.00B | 100.00B | 100.0M | 100.0M | 100.00B | 100.00B | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 10.0M | 10.0M | 10.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Depreciation | $77.7K | $305.8K | $293.1K | $150.1K | $26.5K | $9.5K |
| Prepaid Expense Current | $5.8K | $152.8K | $56.5K | $27.6K | $7.4K | |
| Other Income | $373.5K | $211.3K | $23.2K | $34.6K | ||
| Stock Issued During Period Value Other | $102.3K | $134.9K | $164.0K | |||
| Investment Income Interest | $185.8K | $248.0K | $85.4K | $10.7K | ||
| Additional Paid In Capital | $28.5M | $256.00 | $256.00 | |||
| Stock Issued During Period Value New Issues | $22.2M | |||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $3.3M |
Most recent annual filing with the SEC: October 31, 2025
Data sourced from SEC EDGAR public filings as of August 6, 2026.